Faubel S - Search Results

1

Mechanisms and mediators of lung injury after acute kidney injury.

Faubel S, Edelstein CL. Faubel S, et al. Nat Rev Nephrol. 2016 Jan;12(1):48-60. doi: 10.1038/nrneph.2015.158. Epub 2015 Oct 6. Nat Rev Nephrol. 2016. PMID: 26434402 Review.

2

Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice.

Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL. Melnikov VY, et al. Among authors: faubel s. J Clin Invest. 2002 Oct;110(8):1083-91. doi: 10.1172/JCI15623. J Clin Invest. 2002. PMID: 12393844 Free PMC article.

3

Urinary interleukin-18 is a marker of human acute tubular necrosis.

Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Parikh CR, et al. Among authors: faubel s. Am J Kidney Dis. 2004 Mar;43(3):405-14. doi: 10.1053/j.ajkd.2003.10.040. Am J Kidney Dis. 2004. PMID: 14981598

4

Caspase inhibition prevents the increase in caspase-3, -2, -8 and -9 activity and apoptosis in the cold ischemic mouse kidney.

Jani A, Ljubanovic D, Faubel S, Kim J, Mischak R, Edelstein CL. Jani A, et al. Among authors: faubel s. Am J Transplant. 2004 Aug;4(8):1246-54. doi: 10.1111/j.1600-6143.2004.00498.x. Am J Transplant. 2004. PMID: 15268725 Free article.

5

Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis.

Faubel S, Ljubanovic D, Reznikov L, Somerset H, Dinarello CA, Edelstein CL. Faubel S, et al. Kidney Int. 2004 Dec;66(6):2202-13. doi: 10.1111/j.1523-1755.2004.66010.x. Kidney Int. 2004. PMID: 15569309 Free article.

6

Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice.

Wang W, Faubel S, Ljubanovic D, Mitra A, Falk SA, Kim J, Tao Y, Soloviev A, Reznikov LL, Dinarello CA, Schrier RW, Edelstein CL. Wang W, et al. Among authors: faubel s. Am J Physiol Renal Physiol. 2005 May;288(5):F997-1004. doi: 10.1152/ajprenal.00130.2004. Epub 2005 Jan 11. Am J Physiol Renal Physiol. 2005. PMID: 15644489 Free article.

7

Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD).

Tao Y, Kim J, Stanley M, He Z, Faubel S, Schrier RW, Edelstein CL. Tao Y, et al. Among authors: faubel s. Kidney Int. 2005 Mar;67(3):909-19. doi: 10.1111/j.1523-1755.2005.00155.x. Kidney Int. 2005. PMID: 15698430 Free article.

8

Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.

Tao Y, Kim J, Faubel S, Wu JC, Falk SA, Schrier RW, Edelstein CL. Tao Y, et al. Among authors: faubel s. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6954-9. doi: 10.1073/pnas.0408518102. Epub 2005 Apr 29. Proc Natl Acad Sci U S A. 2005. PMID: 15863619 Free PMC article.

9

Peripheral CD4 T-cell depletion is not sufficient to prevent ischemic acute renal failure.

Faubel S, Ljubanovic D, Poole B, Dursun B, He Z, Cushing S, Somerset H, Gill RG, Edelstein CL. Faubel S, et al. Transplantation. 2005 Sep 15;80(5):643-9. doi: 10.1097/01.tp.0000173396.07368.55. Transplantation. 2005. PMID: 16177639

10

Caspases as drug targets in ischemic organ injury.

Faubel S, Edelstein CL. Faubel S, et al. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Sep;5(3):269-87. doi: 10.2174/1568008054863754. Curr Drug Targets Immune Endocr Metabol Disord. 2005. PMID: 16178788 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page